4:02 PM ET
8-K
Stock Plan Amendment
Myriad Genetics Stock Plan Amendment
Myriad Genetics approved one-time retention stock option awards for its executive leadership team, including the CFO, COO, and CSO. The awards are granted under the 2026 Equity Incentive Plan and will vest fully on the third anniversary of the grant date to ensure leadership continuity during operational efficiency initiatives.